Synapse - Works

Results (5608)

A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)

Meeting Abstract

Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Hu, J. S.; Patil, S.; Reuter, V. E.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Milowsky, M. I.; Appleman, L. J.; Dorff, T. B.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC)

Meeting Abstract

Eastham, J. A.; Heller, G.; Halabi, S.; Monk, P.; Clinton, S. K.; Szmulewitz, R. Z.; Coleman, J.; Gleave, M.; Evans, C. P.; Hillman, D. W.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Consistent efficacy of nivolumab plus ipilimumab across number of International Metastatic Database Consortium (IMDC) risk factors in CheckMate 214

Meeting Abstract

Escudier, B.; Motzer, R. J.; Tannir, N. M.; Porta, C.; Tomita, Y.; Mekan, S. F.; McHenry, M. B.; Rini, B. I.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Infigratinib in upper tract urothelial carcinoma vs urothelial carcinoma of the bladder and association with comprehensive genomic profiling/cell-free DNA results

Meeting Abstract

Dizman, N.; Rosenberg, J. E.; Hoffman-Censits, J. H.; Quinn, D. I.; Petrylak, D. P.; Galsky, M. D.; Vaishampayan, U. N.; De Giorgi, U.; Gupta, S.; Burris, H. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Human prostate cancer immune phenotypes after androgen deprivation therapy

Meeting Abstract

Dallos, M.; Obradovic, A.; Chowdhury, N.; Bujanda, Z. L.; Aggen, D. H.; Hawley, J.; Rathkopf, D. E.; Drake, C. G.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Pembrolizumab (pembro) for patients (pts) with high-risk (HR) non muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guérin (BCG): Updated follow-up from KEYNOTE-057

Meeting Abstract

De Wit, R.; Kulkarni, G. S.; Uchio, E. M.; Krieger, L. E. M.; Boormans, J. L.; Roumiguié, M.; Singer, E. A.; Bajorin, D. F.; Kamat, A. M.; Grivas, P.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A framework for building a clinically relevant risk model

Meeting Abstract

Daly, R. M.; Gorenshteyn, D.; Gazit, L.; Sokolowski, S.; Nicholas, K.; Perry, C.; Adams, L.; Baldwin, A.; Holland, J. C.; Zervoudakis, A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC)

Meeting Abstract

Choueiri, T. K.; Albiges, L.; Haanen, J. B. A. G.; Larkin, J. M. G.; Uemura, M.; Pal, S. K.; Gravis, G.; Campbell, M. T.; Penkov, K.; Lee, J. L.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Evaluation of the patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) with abiraterone acetate plus prednisone (AAP), degarelix (D), or the combination in men with biochemically recurrent prostate cancer (BCRPC)

Meeting Abstract

Autio, K. A.; Antonarakis, E. S.; Baser, R.; Stein, M. N.; Shevrin, D. H.; Vaishampayan, U. N.; Mayer, T. M.; Morris, M. J.; Slovin, S. F.; Heath, E. I.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save